Floatz logo

Therapeutic Asset Ratings

9,920 results matching 1 filter

91,565 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Rimiducid
Her2-Receptor Negative Breast Cancer
Memorial Sloan Kettering Cancer CenterP1CC (43)
Rimiducid
Nasopharyngeal Carcinoma
Poseida Therapeutics, Inc.P1CC (43)
Rimiducid
Neoplasm
M.D. Anderson Cancer CenterP1CC (43)
Rimiducid
Follicular Lymphoma
Poseida Therapeutics, Inc.P1CC (43)
Rimiducid
X-Linked Lymphoproliferative Syndrome
Baylor College of MedicineP1CC (43)
Rituximab
Glioblastoma
University of PennsylvaniaP1CC (43)
Rituximab
Diffuse Large B-Cell Lymphoma Of The Central Nervous System
National Cancer Institute (NCI)P1CC (43)
Rivoceranib
Prostate Cancer
Jiangsu Hansoh Pharmaceutical Co., Ltd.P1CC (43)
rk-582
Metastatic Malignant Neoplasm In The Colon
Eiji ShinozakiP1CC (43)
Rndo-564
Gastroesophageal Junction Adenocarcinoma
Rondo TherapeuticsP1CC (43)
RO7567132
Neoplasm
Hoffmann-La RocheP1CC (43)
ro7790121
Metabolic Dysfunction-Associated Steatohepatitis
Hoffmann-La RocheP1CC (43)
Rocakinogene Sifuplasmid
Hepatitis
National Cancer Institute (NCI)P1CC (43)
Rocakinogene Sifuplasmid
Hepatitis C Virus Infection
National Cancer Institute (NCI)P1CC (43)
Rocbrutinib
B-Cell Non-Hodgkin Lymphoma
Guangzhou Lupeng Pharmaceutical Company LTD.P1CC (43)
Roflumilast
Diffuse Large B-Cell Lymphoma
The University of Texas Health Science Center at San AntonioP1CC (43)
Roginolisib
Myelofibrosis
iOncturaP1CC (43)
Roginolisib
Non-Hodgkin Lymphoma
iOncturaP1CC (43)
Romidepsin
Adult T-Cell Leukemia/Lymphoma
National Cancer Institute (NCI)P1CC (43)
Romidepsin
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma
National Cancer Institute (NCI)P1CC (43)
Romiplostim
Acute Myeloid Leukemia
First Affiliated Hospital of Zhejiang UniversityP1CC (43)
Romiplostim
Myelodysplastic Syndrome
First Affiliated Hospital of Zhejiang UniversityP1CC (43)
Ropeginterferon Alfa-2B
Cancer
PharmaEssentiaP1CC (43)
Ropeginterferon Alfa-2B
Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
H. Lee Moffitt Cancer Center and Research InstituteP1CC (43)
Rosuvastatin
Castration-Resistant Prostate Carcinoma
Aragon Pharmaceuticals, Inc.P1CC (43)
Showing 4076 to 4100 of 9,920 assets
PreviousPage 164 of 397Next